triazoles has been researched along with nystatin a1 in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Cutsem, J | 1 |
| Abruzzo, GK; Bulmer, GS; Fromtling, RA | 1 |
| Holoman, D; Joseph-Horne, T; Kelly, S; Manning, N | 1 |
| Niki, Y | 1 |
| Granier, F | 1 |
| Ellepola, AN; Samaranayake, LP | 1 |
| MOM, AM | 1 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Blackwood, RA; Klein, KC | 1 |
| El-Hawash, SA; Habib, NS; Kassem, MA | 1 |
| Deising, HB; Serfling, A; Wohlrab, J | 1 |
| López-Martínez, R | 1 |
| Huang, CY; Sun, PL; Tseng, HK | 1 |
| de Souza Bonfim-Mendonça, P; Fiorini, A; Godoy, JS; Nakamura, SS; Pieralisi, N; Shinobu-Mesquita, C; Svidzinski, TI; Yamada, SS | 1 |
| Chauhan, NM; Karuppayil, SM; Raut, JS; Shinde, RB | 1 |
| Bulacio, L; Escovich, L; López, C; Pairoba, C; Paz, M; Ramadán, S; Ramos, L; Sortino, M | 1 |
| Kunicka-Styczyńska, A; Maroszyńska, I; Maroszyńska, M; Rajkowska, K | 1 |
| Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E | 1 |
4 review(s) available for triazoles and nystatin a1
| Article | Year |
|---|---|
[Invasive fungal infections. Epidemiology and new therapies].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Microbial; Humans; Immunocompromised Host; Incidence; Nystatin; Risk Factors; Triazoles | 2000 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Candidosis, a new challenge.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Echinocandins; Humans; Imidazoles; Naphthalenes; Nystatin; Terbinafine; Triazoles | 2010 |
Therapeutic tools for oral candidiasis: Current and new antifungal drugs.
Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles | 2019 |
14 other study(ies) available for triazoles and nystatin a1
| Article | Year |
|---|---|
The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Econazole; Female; Miconazole; Microbial Sensitivity Tests; Nystatin; Rats; Rats, Inbred Strains; Triazoles | 1991 |
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles | 1986 |
Nonsterol related resistance in Ustilago maydis to the polyene antifungals, amphotericin B and nystatin.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Fungicides, Industrial; Microbial Sensitivity Tests; Nystatin; Sterols; Triazoles; Ustilago | 1996 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
[Mycostatin: a new fungistatic antibiotic for the treatment of moniliasis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Candidiasis; Dermatologic Agents; Nystatin; Triazoles | 1955 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Topics: Administration, Cutaneous; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bone Marrow Transplantation; Combined Modality Therapy; Debridement; Dermatomycoses; Disease Susceptibility; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Injections, Subcutaneous; Nystatin; Postoperative Complications; Pyrimidines; Skin; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities.
Topics: Anti-Infective Agents; Antineoplastic Agents; Candida albicans; Cefotaxime; Cell Line, Tumor; Cell Survival; Dimethylformamide; Dose-Response Relationship, Drug; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Structure; Nystatin; Quinoxalines; Staphylococcus aureus; Structure-Activity Relationship; Triazoles | 2006 |
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles | 2007 |
Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Dermatomycoses; Female; Humans; Liver Cirrhosis; Mycoses; Nystatin; Paecilomyces; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colony Count, Microbial; Dentures; Diabetes Complications; Echinocandins; Female; Fluconazole; Humans; Hypertension; Kidney Failure, Chronic; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Mycology; Nystatin; Phenotype; Pyrimidines; Renal Dialysis; Time Factors; Triazoles; Voriconazole | 2013 |
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Cyclosporine; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2012 |
Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Fungal; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Nystatin; Opportunistic Infections; Saccharomyces cerevisiae; Species Specificity; Terbinafine; Triazoles | 2012 |
Antibiotics sensitivity of Candida clinical and food-borne isolates.
Topics: Candida; Caspofungin; Drug Resistance, Bacterial; Echinocandins; Fluconazole; Food Microbiology; Foodborne Diseases; Humans; Lipopeptides; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2013 |